Stockreport

CervoMed Announces Key Senior Leadership Appointments

CervoMed Inc.  (CRVO) 
PDF BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, [Read more]